| Year |
Citation |
Score |
| 2024 |
Kar P, Chatrin C, Đukić N, Suyari O, Schuller M, Zhu K, Prokhorova E, Bigot N, Baretić D, Ahel J, Elsborg JD, Nielsen ML, Clausen T, Huet S, Niepel M, et al. Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation. The Embo Journal. PMID 39322761 DOI: 10.1038/s44318-024-00247-6 |
0.524 |
|
| 2024 |
Ledermann R, Bourdès A, Schuller M, Jorrin B, Ahel I, Poole PS. Aspartate aminotransferase of has extended substrate specificity and metabolizes aspartate to enable N fixation in pea nodules. Microbiology (Reading, England). 170. PMID 39073398 DOI: 10.1099/mic.0.001471 |
0.505 |
|
| 2024 |
Rijpkema KJ, Schuller M, van der Veer MS, Rieken S, Chang DLR, Balić P, Todorov A, Minnee H, Wijngaarden S, Matos IA, Hoch NC, Codée JDC, Ahel I, Filippov DV. Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1. Organic Letters. 26: 5700-5704. PMID 38935522 DOI: 10.1021/acs.orglett.4c01792 |
0.629 |
|
| 2024 |
Kar P, Chatrin C, Đukić N, Suyari O, Schuller M, Zhu K, Prokhorova E, Bigot N, Ahel J, Elsborg JD, Nielsen ML, Clausen T, Huet S, Niepel M, Sanyal S, et al. PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation. The Embo Journal. PMID 38834853 DOI: 10.1038/s44318-024-00126-0 |
0.613 |
|
| 2024 |
Cihlova B, Lu Y, Mikoč A, Schuller M, Ahel I. Specificity of DNA ADP-Ribosylation Reversal by NADARs. Toxins. 16. PMID 38787060 DOI: 10.3390/toxins16050208 |
0.686 |
|
| 2024 |
Wondisford AR, Lee J, Lu R, Schuller M, Groslambert J, Bhargava R, Schamus-Haynes S, Cespedes LC, Opresko PL, Pickett HA, Min J, Ahel I, O'Sullivan RJ. Deregulated DNA ADP-ribosylation impairs telomere replication. Nature Structural & Molecular Biology. PMID 38714889 DOI: 10.1038/s41594-024-01279-6 |
0.608 |
|
| 2023 |
Đukić N, Strømland Ø, Elsborg JD, Munnur D, Zhu K, Schuller M, Chatrin C, Kar P, Duma L, Suyari O, Rack JGM, Baretić D, Crudgington DRK, Groslambert J, Fowler G, et al. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities. Science Advances. 9: eadi2687. PMID 37703374 DOI: 10.1126/sciadv.adi2687 |
0.646 |
|
| 2023 |
Schuller M, Raggiaschi R, Mikolcevic P, Rack JGM, Ariza A, Zhang Y, Ledermann R, Tang C, Mikoc A, Ahel I. Molecular basis for the reversible ADP-ribosylation of guanosine bases. Molecular Cell. 83: 2303-2315.e6. PMID 37390817 DOI: 10.1016/j.molcel.2023.06.013 |
0.666 |
|
| 2023 |
Suskiewicz MJ, Munnur D, Strømland Ø, Yang JC, Easton LE, Chatrin C, Zhu K, Baretić D, Goffinont S, Schuller M, Wu WF, Elkins JM, Ahel D, Sanyal S, Neuhaus D, et al. Updated protein domain annotation of the PARP protein family sheds new light on biological function. Nucleic Acids Research. PMID 37326024 DOI: 10.1093/nar/gkad514 |
0.738 |
|
| 2023 |
Longarini EJ, Dauben H, Locatelli C, Wondisford AR, Smith R, Muench C, Kolvenbach A, Lynskey ML, Pope A, Bonfiglio JJ, Jurado EP, Fajka-Boja R, Colby T, Schuller M, Ahel I, et al. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling. Molecular Cell. PMID 37116497 DOI: 10.1016/j.molcel.2023.03.027 |
0.626 |
|
| 2023 |
Schuller M, Zarganes-Tzitzikas T, Bennett J, De Cesco S, Fearon D, von Delft F, Fedorov O, Brennan PE, Ahel I. Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors. Pathogens (Basel, Switzerland). 12. PMID 36839595 DOI: 10.3390/pathogens12020324 |
0.627 |
|
| 2023 |
Gahbauer S, Correy GJ, Schuller M, Ferla MP, Doruk YU, Rachman M, Wu T, Diolaiti M, Wang S, Neitz RJ, Fearon D, Radchenko DS, Moroz YS, Irwin JJ, Renslo AR, et al. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 120: e2212931120. PMID 36598939 DOI: 10.1073/pnas.2212931120 |
0.657 |
|
| 2022 |
Hloušek-Kasun A, Mikolčević P, Rack JGM, Tromans-Coia C, Schuller M, Jankevicius G, Matković M, Bertoša B, Ahel I, Mikoč A. macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA. Computational and Structural Biotechnology Journal. 20: 4337-4350. PMID 36051881 DOI: 10.1016/j.csbj.2022.08.002 |
0.773 |
|
| 2022 |
Gahbauer S, Correy GJ, Schuller M, Ferla MP, Doruk YU, Rachman M, Wu T, Diolaiti M, Wang S, Neitz RJ, Fearon D, Radchenko D, Moroz Y, Irwin JJ, Renslo AR, et al. Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 35794891 DOI: 10.1101/2022.06.27.497816 |
0.626 |
|
| 2022 |
Schuller M, Ahel I. Beyond protein modification: the rise of non-canonical ADP-ribosylation. The Biochemical Journal. 479: 463-477. PMID 35175282 DOI: 10.1042/BCJ20210280 |
0.629 |
|
| 2021 |
Schuller M, Butler RE, Ariza A, Tromans-Coia C, Jankevicius G, Claridge TDW, Kendall SL, Goh S, Stewart GR, Ahel I. Molecular basis for DarT ADP-ribosylation of a DNA base. Nature. PMID 34408320 DOI: 10.1038/s41586-021-03825-4 |
0.768 |
|
| 2021 |
Bajusz D, Wade WS, Satała G, Bojarski AJ, Ilaš J, Ebner J, Grebien F, Papp H, Jakab F, Douangamath A, Fearon D, von Delft F, Schuller M, Ahel I, Wakefield A, et al. Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications. 12: 3201. PMID 34045440 DOI: 10.1038/s41467-021-23443-y |
0.593 |
|
| 2021 |
Schuller M, Correy GJ, Gahbauer S, Fearon D, Wu T, Díaz RE, Young ID, Carvalho Martins L, Smith DH, Schulze-Gahmen U, Owens TW, Deshpande I, Merz GE, Thwin AC, Biel JT, et al. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Science Advances. 7. PMID 33853786 DOI: 10.1126/sciadv.abf8711 |
0.639 |
|
| 2020 |
Schuller M, Correy GJ, Gahbauer S, Fearon D, Wu T, Díaz RE, Young ID, Martins LC, Smith DH, Schulze-Gahmen U, Owens TW, Deshpande I, Merz GE, Thwin AC, Biel JT, et al. Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking. Biorxiv : the Preprint Server For Biology. PMID 33269349 DOI: 10.1101/2020.11.24.393405 |
0.642 |
|
| 2020 |
Rack JGM, Zorzini V, Zhu Z, Schuller M, Ahel D, Ahel I. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biology. 10: 200237. PMID 33202171 DOI: 10.1098/rsob.200237 |
0.601 |
|
| 2018 |
Moustakim M, Riedel K, Schuller M, Gehring AP, Monteiro OP, Martin SP, Fedorov O, Heer J, Dixon DJ, Elkins JM, Knapp S, Bracher F, Brennan PE. Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. Bioorganic & Medicinal Chemistry. PMID 29567296 DOI: 10.1016/J.Bmc.2018.03.020 |
0.588 |
|
| 2017 |
Schuller M, Riedel K, Gibbs-Seymour I, Uth K, Sieg C, Gehring AP, Ahel I, Bracher F, Kessler BM, Elkins JM, Knapp S. Discovery of a selective allosteric inhibitor targeting macrodomain 2 of poly-adenosine-diphosphate-ribose polymerases 14. Acs Chemical Biology. PMID 28991428 DOI: 10.1021/Acschembio.7B00445 |
0.718 |
|
| 2015 |
Froese DS, Kopec J, Fitzpatrick F, Schuller M, McCorvie TJ, Chalk R, Plessl T, Fettelschoss V, Fowler B, Baumgartner MR, Yue WW. Structural insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking. The Journal of Biological Chemistry. PMID 26483544 DOI: 10.1074/jbc.M115.683268 |
0.316 |
|
| Show low-probability matches. |